Inpharma Weekly

, Volume 1365, Issue 1, pp 4–4 | Cite as

Antibacterials to treat resistant pathogens could be approved based on limited phase III study data,

News item


Development Programme Limited Range Great Benefit Study Data Drug Product 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 2002

Personalised recommendations